![Katsuhiko Hatazawa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Katsuhiko Hatazawa
Directeur/Membre du Conseil chez Spera Pharma, Inc.
Profil
Katsuhiko Hatazawa currently works at Jitsubo Co., Ltd., as Director and Spera Pharma, Inc., as Director.
Postes actifs de Katsuhiko Hatazawa
Sociétés | Poste | Début |
---|---|---|
Spera Pharma, Inc.
![]() Spera Pharma, Inc. Pharmaceuticals: MajorHealth Technology Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan. | Directeur/Membre du Conseil | - |
Jitsubo Co., Ltd.
![]() Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Spera Pharma, Inc.
![]() Spera Pharma, Inc. Pharmaceuticals: MajorHealth Technology Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan. | Health Technology |
Jitsubo Co., Ltd.
![]() Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Health Technology |